Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective

A Kumar, AK Singh, H Singh, V Vijayan, D Kumar… - Pharmaceuticals, 2023 - mdpi.com
Cancer is one of the major healthcare challenges across the globe. Several anticancer
drugs are available on the market but they either lack specificity or have poor safety, severe …

Recent advances in pyridine scaffold: Focus on chemistry, synthesis, and antibacterial activities

MB Islam, MI Islam, N Nath, TB Emran… - BioMed research …, 2023 - Wiley Online Library
Multidrug‐resistant (MDR) pathogens have created a fatal problem for human health and
antimicrobial treatment. Among the currently available antibiotics, many are inactive against …

Recent advances in the development of pyrazole derivatives as anticancer agents

Y Zhang, C Wu, N Zhang, R Fan, Y Ye, J Xu - International Journal of …, 2023 - mdpi.com
Pyrazole derivatives, as a class of heterocyclic compounds, possess unique chemical
structures that confer them with a broad spectrum of pharmacological activities. They have …

Synthesis, molecular docking and antimicrobial activity of new fused pyrimidine and pyridine derivatives

MAA Radwan, MA Alshubramy, M Abdel-Motaal… - Bioorganic …, 2020 - Elsevier
Synthesis of some new heterocyclic ring systems incorporated pyrimidine and pyridine
moieties starting from 1-(furan-2-yl)-3-(thiophen-2-yl) chalcone was achieved. The structure …

Naproxen based 1, 3, 4-oxadiazole derivatives as EGFR inhibitors: Design, synthesis, anticancer, and computational studies

MM Alam, S Nazreen, ASA Almalki, AA Elhenawy… - Pharmaceuticals, 2021 - mdpi.com
A library of novel naproxen based 1, 3, 4-oxadiazole derivatives (8–16 and 19–26) has been
synthesized and screened for cytotoxicity as EGFR inhibitors. Among the synthesized …

New 1, 3, 4‐oxadiazoles linked with the 1, 2, 3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase

MA Mahmoud, AF Mohammed, OIA Salem… - Archiv der …, 2022 - Wiley Online Library
Abstract A series of 1, 3, 4‐oxadiazole‐1, 2, 3‐triazole hybrids bearing different
pharmacophoric moieties has been designed and synthesized. Their antiproliferative activity …

Anticancer evaluation and molecular docking of new pyridopyrazolo-triazine and pyridopyrazolo-triazole derivatives

MR Elmorsy, E Abdel-Latif, HE Gaffer, SE Mahmoud… - Scientific Reports, 2023 - nature.com
Amino-4, 6-dimethylpyrazolopyridine was applied as a precursor for the synthesis of some
new pyridopyrazolo-triazine and pyridopyrazolo-triazole derivatives through diazotization …

Synthesis and molecular docking study of novel pyrimidine derivatives against COVID-19

ZM Alamshany, RR Khattab, NA Hassan, AA El-Sayed… - Molecules, 2023 - mdpi.com
A novel series of pyrido [2, 3-d] pyrimidines; pyrido [3, 2-e][1, 3, 4] triazolo; and tetrazolo [1, 5-
c] pyrimidines were synthesized via different chemical transformations starting from pyrazolo …

One-pot three-component synthesis of novel pyrazolo [3, 4-b] pyridines as potent antileukemic agents

RF Barghash, WM Eldehna, M Kovalova… - European Journal of …, 2022 - Elsevier
In the current study, we report on the development of novel series of pyrazolo [3, 4-b]
pyridine derivatives (8a-u, 11a-n, and 14a, b) as potential anticancer agents. The prepared …

Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance

RH Abd El-Aleam, RF George, HH Georgey… - RSC …, 2021 - pubs.rsc.org
Antibiotic resistance is one of the most important challenges of the 21st century. However,
the growing understanding of bacterial pathogenesis and cell-to-cell communication has …